Brainstorm Cell Therapeutics | BCLI - Ordinary Share Capital


Brainstorm Cell Therapeutics reported $15K in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Biogen USD 146.7M 200K Sep/2025
Brainstorm Cell Therapeutics USD 15K 1000 Mar/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
Grifols EUR 679.73M 0 Sep/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Mesoblast USD 1.28B 127.49M Jun/2025